Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
Pharma News, 2021
EC approval for Ontozry
Angelini Pharma has announced European Commission (EC) approval for anti-seizure drug Ontozry (cenobamate).
Lab-grown meat uses spinach ‘skeletons’ for greener process
Researchers with Boston College have successfully used spinach ‘skeletons’ as scaffolding to grow bovine cells in a lab, paving the way for a greener, cheaper method to produce beef.
Phase 1 clinical trial of unique COVID-19 vaccine begins
A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the Walter Reed Army Institute of Research (WRAIR), part of the U.
Scientists show you can collect DNA from the air
Scientists and investigators might not need to scoop up DNA from surfaces in the future.
Servier Completes Acquisition of Agios Pharmaceuticals’ Oncology Business
PARIS, France and BOSTON, Mass.
FDA approves 2 rapid coronavirus tests to be sold over-the-counter for at-home use
The U.
FDA approves alirocumab for treating homozygous familial hypercholesterolemia
The FDA has approved alirocumab as a treatment option for homozygous familial hypercholesterolemia (HoFH), a condition associated with severely high cholesterol.
FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma
PARIS – March 31, 2021- The U.
Exclusive: Fauci says U.S. may not need AstraZeneca COVID-19 vaccine
CHICAGO (Reuters) - The United States may not need AstraZeneca’s COVID-19 vaccine, even if it wins U.
Scientists find genetic link to clogged arteries
High cholesterol is the most commonly understood cause of atherosclerosis, a hardening of the arteries that raises the risk of heart attack and stroke.
Novel pharmacological strategies to treat alcoholism. Focus on epigenetics
Abusive alcohol drinking considerably impacts human health.
Why Johnson & Johnson throwing out 15 million COVID-19 vaccine doses shouldn’t scare you
Human errors at a manufacturing plant forced Johnson & Johnson to throw out 15 million doses of its COVID-19 vaccine – enough to vaccinate 7% of the U.
54
55
56
57
58
59
60
61
62
